Common Contracts
6 similar Underwriting Agreement contracts by Cardica Inc, AxoGen, Inc., Dynavax Technologies Corp
AXOGEN, INC. 4,728,000 Shares of Common Stock UNDERWRITING AGREEMENTUnderwriting Agreement • February 5th, 2015 • AxoGen, Inc. • Electromedical & electrotherapeutic apparatus • New York
AxoGen, Inc., a Minnesota corporation (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell to Wedbush Securities Inc. (the “Underwriter”) an aggregate of 4,728,000 shares (the “Firm Securities”) of its common stock, $0.01 par value per share (the “Common Stock”). The Company has granted the Underwriter the option to purchase an aggregate of up to 709,200 additional shares of Common Stock (the “Option Securities”) as may be necessary to cover over-allotments made in connection with the offering pursuant to Section 2(b) hereof. The Firm Securities and the Option Securities are collectively referred to as the “Securities.” The Company and the Underwriter hereby confirm their agreement with respect to the purchase and sale of the Securities as follows:
CARDICA, INC. [●] Shares of Common Stock and [●] Shares of Series A Convertible Preferred Stock UNDERWRITING AGREEMENTUnderwriting Agreement • April 14th, 2014 • Cardica Inc • Surgical & medical instruments & apparatus • New York
Cardica Inc., a Delaware corporation (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell to Wedbush Securities Inc. (“Wedbush”) and Craig-Hallum Capital Group LLC (“Craig-Hallum” and, together with Wedbush, the “Underwriters”), for whom Wedbush is acting as representative, an aggregate of [●] shares of its common stock, $0.001 par value per share (the “Common Stock”) and [●] shares of Series A Convertible Preferred Stock, $0.001 par value per share (the “Preferred Stock” and, together with the Common Stock, the “Firm Securities”). In addition, the Company proposes to grant to the Underwriters an option to purchase an additional [●] shares of its Common Stock (the “Optional Securities”) for the purpose of covering over-allotments in connection with the sale of the Firm Securities. The Firm Securities and the Optional Securities which the Underwriters elect to purchase pursuant to Section 2(a) hereof are hereinafter collectively called the “Sec
CARDICA, INC. [●] Shares of Common Stock UNDERWRITING AGREEMENTUnderwriting Agreement • February 20th, 2014 • Cardica Inc • Surgical & medical instruments & apparatus • New York
Cardica Inc., a Delaware corporation (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell to Wedbush Securities Inc. (“Wedbush”) and Craig-Hallum Capital Group LLC (“Craig-Hallum” and, together with Wedbush, the “Underwriters”), for whom Wedbush is acting as representative, an aggregate of [●] shares (the “Firm Securities”) of its common stock, $0.001 par value per share (the “Common Stock”). In addition, the Company proposes to grant to the Underwriters an option to purchase an additional [●] shares of its Common Stock (the “Optional Securities”) for the purpose of covering over-allotments in connection with the sale of the Firm Securities. The Firm Securities and the Optional Securities which the Underwriters elect to purchase pursuant to Section 2(a) hereof are hereinafter collectively called the “Securities”.
CARDICA, INC. 14,251,368 Shares of Common Stock UNDERWRITING AGREEMENTUnderwriting Agreement • March 15th, 2013 • Cardica Inc • Surgical & medical instruments & apparatus • New York
Cardica Inc., a Delaware corporation (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell to Wedbush Securities Inc. (the “Underwriter”) an aggregate of 14,251,368 shares (the “Securities”) of its common stock, $0.001 par value per share (the “Common Stock”). The Company and the Underwriter hereby confirm their agreement with respect to the purchase and sale of the Securities as follows:
CARDICA, INC. 9,091,000 Shares of Common Stock UNDERWRITING AGREEMENTUnderwriting Agreement • February 8th, 2012 • Cardica Inc • Surgical & medical instruments & apparatus • New York
Cardica Inc., a Delaware corporation (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell to Wedbush Securities Inc. (the “Underwriter”) an aggregate of 9,091,000 shares (the “Securities”) of its common stock, $0.001 par value per share (the “Common Stock”). The Company and the Underwriter hereby confirm their agreement with respect to the purchase and sale of the Securities as follows:
DYNAVAX TECHNOLOGIES CORPORATION 30,293,000 Units Each Unit consisting of One Share of Common Stock and One Warrant to Purchase 0.5 of a Share of Common Stock UNDERWRITING AGREEMENTUnderwriting Agreement • April 13th, 2010 • Dynavax Technologies Corp • Pharmaceutical preparations • New York
Dynavax Technologies Corporation, a Delaware corporation (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell to Wedbush Securities Inc. (the “Underwriter”) an aggregate of (i) 30,293,000 shares (the “Shares”) of its common stock, $0.001 par value per share (the “Common Stock”), and (ii) warrants (the “Warrants”) to purchase up to an aggregate of 15,146,500 shares of Common Stock (the “Warrant Shares” and, collectively with the Shares and the Warrants, the “Securities”). The Shares and Warrants shall be sold in units (the “Units”), each Unit consisting of one (1) Share and one (1) Warrant to purchase 0.5 of a Warrant Share at the exercise price per share specified in the Prospectus (as defined below). The Shares and the Warrants will be issued separately and shall be immediately separable and transferable upon issuance. The Warrants will be in substantially the form attached hereto as Exhibit A.
